Related Experiment Video
Updated: Sep 18, 2026

Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
Published on: December 23, 2016
Virus threshold determines disease in SIVsmmPBj14-infected macaques
S P O'Neil1, S P Mossman, D H Maul
1Department of Pathology, Colorado State University, Fort Collins 80523, USA.
Abstract:
Simian immunodeficiency virus (SIV) variant SIVsmmPBj14 is unique in producing an acutely lethal enteropathic syndrome in pigtail macaques. To determine whether the nature of the PBj14 disease would be attenuated by decreasing virus input and to relate tissue virus burden to the severity of disease, we infected pigtail macaques with serial 10-fold doses of SIVsmmPBj14 clone bcl.3 spanning 10(-2) through 10(4)TCID50. The results revealed a strikingly narrow difference between minimum infectious and fatal disease-inducing doses and a close association between enteric lymphoid tissue virus burden and disease. All animals infected with as much as 10(4) TCID50 through as little as 100 TCID50 of virus died of the lethal PBj14 syndrome between 7 and 13 days postinfection. Animals receiving 10(-1) TCID50 became infected (PCR+) but did not develop clinical disease. Animals receiving 10(-2) TCID50 did not become infected. The clinical syndrome was surprisingly similar in all affected macaques, although the time to disease onset and total survival time increased slightly as virus input decreased from 10(4) to 10 degrees TCID50. Highest terminal virus loads in plasma, gut-associated lymphoid tissue (GALT), and lymph nodes and greatest lesion severity were attained at intermediate levels of virus input (10(1) to 10(2) TCID50), probably owing to optimal time for virus amplification in target tissues. The present study reinforces others on the PBj14 system, suggesting that once a threshold level of virus replication is attained in intestinal lymphoid tissues, the cascade of events precipitating the lethal PBj14 syndrome is triggered irreversibly.
Insights
Simian immunodeficiency virus (SIV) PBj14 causes lethal enteritis in macaques. Even low virus doses trigger fatal disease, with gut lymphoid tissue viral load closely linked to severity.
Area of Science:
- Virology
- Immunology
- Pathogenesis
Background:
- Simian immunodeficiency virus (SIV) SIVsmmPBj14 induces a unique, acutely lethal enteropathic syndrome in pigtail macaques.
- Understanding the dose-response relationship and tissue viral burden is crucial for characterizing SIV-induced disease.
Purpose of the Study:
- To investigate the impact of decreasing SIVsmmPBj14 viral input on disease severity.
- To correlate tissue viral burden with the observed clinical and pathological outcomes.
Main Methods:
- Pigtail macaques were infected with serial 10-fold dilutions of SIVsmmPBj14 (10^-2 to 10^4 TCID50).
- Clinical signs, survival times, and viral loads in plasma and lymphoid tissues (gut-associated lymphoid tissue [GALT] and lymph nodes) were monitored.
- Lesion severity was assessed to quantify pathological changes.
Main Results:
- A narrow window exists between the minimum infectious dose and the fatal disease-inducing dose of SIVsmmPBj14.
- Infection with doses as low as 100 TCID50 resulted in lethal PBj14 syndrome, with onset 7-13 days post-infection.
- Peak viral loads and lesion severity occurred at intermediate doses (10^1 to 10^2 TCID50), suggesting optimal amplification for disease induction.
- Viral burden in GALT strongly correlated with disease severity.
Conclusions:
- A threshold level of viral replication in intestinal lymphoid tissues is sufficient to trigger the irreversible cascade leading to lethal SIV-induced enteropathy.
- The SIVsmmPBj14 model demonstrates a tight link between initial viral dose, tissue viral burden, and the progression of acute, lethal disease.
More Related Videos
13:13Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
Published on: September 25, 2018
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019